Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix SA emerged from stealth today as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of ...

Epigenome editing has followed a similar path, in that more recent technological breakthroughs have enabled scientists to apply the discoveries made in previous decades. Epigenome editing performs a ...

Elena Erroba is the group CCO at 3PBIOVIAN. She specializes in the development and manufacturing of recombinant proteins and advanced therapies, including viral vectors—such as adenoviruses and ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as ...

A clinical review of a novel blood test use in rural Alabama for multi-cancer detection, analyzing methylation patterns of cell-free DNA and future strategies. This is an ASCO Meeting Abstract from ...

The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...